News & Views - Page 10

Officials with the FDA have approved enasidenib (Idhifa, Celgene Corporation) for the treatment relapsed or refractory acute myeloid leukemia (AML) in adult patients who have a specific genetic mutation, isocitrate dehydrogenase-2 (IDH2), according to a FDA press release.
Jeannette Y. Wick, RPh, MBA, FASCP
The FDA has issued a safety warning for intravitreal (eye) injections of a compounded drug containing triamcinolone and moxifloxacin.
Tennessee drug company Crown Laboratories Inc. has agreed to cease manufacturing and halt distribution of unapproved and misbranded dermatologic products.
In a company press release, Intellipharmaceutics announced that an FDA panel voted against recommending its abuse-deterrent oxycodone hydrochloride extended release tablets, Rexista, for approval.
Jennifer Barrett, Assistant Editor
Every year, viewers tune into the Discovery Channel's highly anticipated Shark Week. Sharks often get a bad reputation, but they can actually play key roles in finding new treatments for diseases.
A draft recommendation statement from the US Preventive Services Task Force (USPSTF) advises against routine screening for women who have no signs or symptoms of ovarian cancer.
As of 2015, 30.3 million Americans – or 9.4% of the US population – have diabetes and another 84.1 million Americans have prediabetes, according to a recently-released report from the Centers for Disease Control and Prevention.

Current Issue

The Educated Patient

Sara Marlow, MSN, RN, PHN, FNP-C
Sunburn is still a major health issue that can be prevented.
Kristen Marjama, DNP, FNP-BC
The National Health Interview Survey in 2014 estimated that 17.7 million adults and 6.3 million children had asthma.
Mary McCormack, MSN, APNC, MPH
The World Gastroenterology Organization describes the prevalence of celiac disease as a “statistical iceberg” in today’s health climate.
Melissa DeCapua, DNP, PMHNP-B-C
Diabetic retinopathy causes more losses of vision worldwide than any other eye disease, affecting 33% of the 285 million individuals suffering from diabetes.
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Contact Us
Terms & Conditions
Pharmacy Healthcare & Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2017
Pharmacy Healthcare & Communications, LLC. All Rights Reserved.